All About Injectables and Poster Awards | ASM 2022

This session was recorded at the AACS Annual Scientific Meeting on February 3-5, 2022. This is a non-CME course and is approximately 3 hours in length.


  • $0 - AACS Member (Training Fellow or Resident)
  • $120 - AACS Member (Physician or Allied Health)
  • $240 - Non-Member Practitioner

Target Audience

Practitioners in the field of cosmetic surgery including, but not limited to, dermatology, oral and maxillofacial surgery, otolaryngology, general surgery, ophthalmology, and plastic/reconstructive surgery.

Poster Awards

Presented by:

Alexander W. Sobel, DO, FAACS
Vice President, Cosmetic Surgery Foundation

1st Place: Donovan Reed, MD 

2nd Place: Artur Rozentsvit, DO 

3rd Place: Abby Duplechain and Rishal Ambaram, MD, DDS 


Lisa Chipps, MD, MS, FAAD, FAACS
Moy-Fincher-Chipps Facial Plastics/Dermatology, Beverly Hills, CA

Ed Zimmerman, MD
Aesthetic Revolution Las Vegas, NV


Chin Filler Pearls

Joe Niamtu, III, DMD
Niamtu Cosmetic Facial Surgery, Richmond, VA

Chin filler is an option for chin augmentation but has significant limitations and those providing treatment must understand surgical options and discuss with prospective patients.

Lip Tips and More

Trevor Larsen, RN
Tru Beauty by Trevor, Las Vegas, NV

Poly L Lactic Acid 

Melanie Palm, MD, MBA 
Art of Skin MD, Solana Beach, CA

Dilute and Hyper-Dilute Fillers as Activators from Nose to Toes

Ed Zimmerman, MD
Aesthetic Revolution Las Vegas, NV

Dermapose: Update and Use for Fat Grafting

Sheila C. Barbarino, MD, FACS
Barbarino Surgical Arts, Austin, TX

CVA After Noninvasive Deep Dermal Heating and Placement of Hyaluronidase

The Ferguson Clinic, Honolulu, HI

My goal is to have a discussion with the presentation attendees regarding the possible mechanisms that may have led to this complication.

Facial Danger Zones

Mark Mandell-Brown, MD, FAACS
Mandell-Brown Plastic Surgery Center, Cincinnati, OH

To provide a guideline by which to implement hyaluronidase management necessary for each type of HA filler in the setting of filler-induced vascular obstruction. These in vitro studies on every HA filler on the US market currently can help propel in vivo clinical guidelines tailored specifically for each type of filler. More importantly, this can serve as a foundation for beginning injectors to choose filler products that are known to dissolve readily rather than those that might take longer to dissolve.

In Vitro Analysis of Degradation of 18 HA-Based Dermal Fillers with Tailored Hyaluronidase Dosing to Achieve Urgent Reversal of Vascular Complications

Sahitya Reddy, MD
Sanctuary Cosmetic Center/Rostami OPC, Dulles, VA

Adverse Injection Events: Prevent and Treat

Lisa Chipps, MD, MS, FAAD, FAACS
Moy-Fincher-Chipps Facial Plastics/Dermatology, Beverly Hills, CA

Course summary
Available credit: 
  • 3.00 Contact Hour(s)
Course opens: 
Course expires: 

This is a non-CME course. 

Available Credit

  • 3.00 Contact Hour(s)
Please login or register to take this course.

This is a non-CME course. Registration fees are non-refundable.